A review of ropinirole prolonged release in Parkinson’s disease

Muhammad M Nashatizadeh, Kelly E Lyons, Rajesh PahwaDepartment of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USAAbstract: Ropinirole prolonged release is a once-daily, 24-hour formulation of ropinirole, a non-ergot dopamine agonist. It is approved as monotherapy and as an a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Muhammad M Nashatizadeh, Kelly E Lyons, Rajesh Pahwa
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://doaj.org/article/9df572a6b87b430eacb1de5fbc299229
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!